[PDF] Top 20 The development of sialidase inhibitors using structure based drug design
Has 10000 "The development of sialidase inhibitors using structure based drug design" found on our website. Below are the top 20 most common "The development of sialidase inhibitors using structure based drug design".
The development of sialidase inhibitors using structure based drug design
... molecular structure, interaction and reactivity can be useful in the dissection of mechanisms and interactions in large biological molecules (Science, ...function using chemical tools (Stockwell, 2004, ... See full document
244
Structure-based design of anticancer prodrug PABA/NO
... Structure-based drug design is a growing fi eld in which remarkable advances have been made in recent years (Anderson 2003; Scapin ...the development of PABA/NO was briefl y mentioned ... See full document
8
COMPUTER AIDED DRUG DESIGN: AN OVERVIEW
... and development of a new drug is generally known as a very complex process which takes a lot of time and ...aided drug design approaches are used very widely to increase the efficiency of the ... See full document
6
Structure-based drug design: aiming for a perfect fit.
... three-dimensional structure of therapeutically relevant targets has in- formed drug discovery since the first protein structures were determined using X-ray crys- tallography in the 1950s and ...of ... See full document
7
Computational Drug Designing and Development: An insight
... ligand based drug designing. Direct drug designing is based on information of ...the structure of target, it is also named as Structure based drug ...of ... See full document
5
Structure based drug design for ndm1 inhibitors identification of antibacterial resistance
... NDM-1 inhibitors from Chembridge database using Virtual screening and molecular docking ...the development of a novel potential inhibitor of NDM-1, which may be considered as a potential drug ... See full document
6
STUDY OF STRUCTURE BASED DESIGN FOR SULFONES AS ENOYL ACP REDUCTASE INHIBITORS
... the structure of the target protein, candidate drugs that are predicted to bind with high affinity and selectivity to the target may be designed using interactive ...putative drug compounds in the ... See full document
7
HOMOLOGY MODELING AND DOCKING STUDIES ON HIV REVERSE TRANSRIPTASE INHIBITORS
... so-called drug analogs account for about half of all "new" drugs and are of tremendous importance both for medical and financial ...addition, drug analogs can be modeled on naturally occurring ... See full document
20
In Silico Approach for the Identification of Potential Targets and Specific Antimicrobials for Streptococcus mutans
... rational design of new compound-prototypes allow- ing to plan the chemical structure of a new molecule based on the previous definition of the therapeutic action mechanism, ...molecular ... See full document
13
Identification of novel, in vivo active Chk1 inhibitors utilizing structure guided drug design
... through structure-based elaboration of a fragment core designed for binding at a kinase ATP- binding ...[15] inhibitors have undergone clinical ...Chk1 inhibitors as inhibiting it would ... See full document
16
The discovery of potent ribosomal S6 kinase inhibitors by high- throughput screening and structure-guided drug design
... present. Although the S6K1 construct is considerably shorter than the PKA and PKA-S6K1 chimera sequences, the overall tertiary SK61 structure is very similar to the PKA-S6K1 chimera (rmsd 1.33 Å for 247 equivalent ... See full document
15
Structure–activity relationships study of mTOR kinase inhibition using QSAR and structure-based drug design approaches
... mTOR inhibitors is still a point of concern as the comprehension of the underlying relationships between the structural variations in the inhibitors and their inhibition capacity of mTOR kinase is a crucial ... See full document
9
Molecular docking as a popular tool in drug design, an in silico travel
... the development of increasingly more sophisticated computational tools, SBDD is becoming a key step in the development of target-based ...assisted drug design in the discovery of new ... See full document
11
Structure-based design of selective and potent G quadruplex-mediated telomerase inhibitors
... The first two compounds, 3 and 4, in this generation of acridine molecules are shown in Fig. 1, having anilino subsituents at the 9-position. Retention of the acridine chromophore ensures that electrostatic interactions ... See full document
6
Structure based design, synthesis, and pharmacologic evaluation tf peptide RGS4 inhibitors
... 120 -residue homologous domain (defined as the RGS domain) was described in several proteins at approximately the same time ( 1 , 2 ) and was demonstrated to be responsible for binding of the RGS protein to the G-protein ... See full document
6
Structure-Based Design of Inhibitors Against Maltosyltransferase Glge
... employed. The top three lead compounds, ZINC39010596, ZINC31163371 and ZINC31166471 were the ones modified using the De Novo Evolution protocol. In the De Novo Evolution protocol of DS2.5, modifications (i.e. ... See full document
9
Structure Based Drug Design and Synthesis of Ibuprofen analogs as Cox Inhibitors
... The structure based drug design (SBDD) was performed against 3NT1 protein using XP on Dell Precision T-1500 workstation. About 1000 molecules having various heterocyclic rings of ... See full document
8
In Silico Designing of Novel Thiazolidine-2-one Derivatives as Dual PDE4/7 Inhibitors for Inflammatory Disorders
... Dual inhibitors of PDE4/7 are a novel class of drug candidates which can regulate pro-inflammatory as well as function of immune T-cell and are particularly beneficial for the treatment of various ... See full document
14
Identification of novel PTPRQ phosphatase inhibitors based on the virtual screening with docking simulations
... PTP receptor type Q (PTPRQ) is a member of the receptor type PTP family that con- tains 18 extracellular fibronectin domains and one cytoplasmic catalytic domain. Al- though the primary sequence of the catalytic domain ... See full document
10
High consistency of structure-based design and X-ray crystallography: Design, synthesis, kinetic evaluation and crystallographic binding mode determination of biphenyl-N-acyl- -D-glucopyranosylamines as glycogen phosphorylase inhibitors
... collected using a Cu X-ray microfocus source (Oxford Diffraction SuperNova) equipped with a 4 kappa goniometer and the ATLAS CCD (135 mm) detector at room ...selected based on the CC 1/2 ... See full document
13
Related subjects